Literature DB >> 22836626

Plasma selectins in patients with obstructive sleep apnea.

S Cofta1, E Wysocka, S Dziegielewska-Gesiak, S Michalak, T Piorunek, H Batura-Gabryel, L Torlinski.   

Abstract

Obstructive sleep apnea (OSA) is an independent risk factor in the pathogenesis of -cardiovascular diseases. The aim of the study was to analyze three specific adhesion molecules involved in the development of an atherosclerotic plaque: E-selectin (endothelium), L-selectin (leukocyte surface), and P-selectin (from platelet), circulating in plasma in patients at different OSA severity. Eighty non-smoking male Caucasians aged 30-64 were enrolled into the study after clinical, biochemical, and polysomnographic examinations. The patients were divided into four groups based on the results of apnea/hypopnea index (AHI): OSA-0 with AHI 0-4.9 (n = 20), OSA-1 with AHI 5-15 (n = 21), OSA-2 with AHI 16-30 (n = 18), OSA-3 with AHI ≥ 31 (n = 21). Complete blood count, oral glucose tolerance test, fasting lipid profile, C-reactive protein and insulin, and plasma concentrations of soluble E-selectin, P-selectin and L-selectin were measured. We found a progressive increase in the concentrations of all three selectins with the severity of OSA. In conclusion, the level of plasma adhesion molecules may be indicative of OSA severity and may contribute to cardiovascular sequelae.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22836626     DOI: 10.1007/978-94-007-4549-0_15

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  11 in total

Review 1.  Biomarkers associated with obstructive sleep apnea: A scoping review.

Authors:  Graziela De Luca Canto; Camila Pachêco-Pereira; Secil Aydinoz; Paul W Major; Carlos Flores-Mir; David Gozal
Journal:  Sleep Med Rev       Date:  2014-11-28       Impact factor: 11.609

Review 2.  Soluble P-selectin levels in patients with obstructive sleep apnea: a systematic review and meta-analysis.

Authors:  Ding Zhu; Zhibo Xu; Tingting Liu; Yaqing Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-05-05       Impact factor: 2.503

3.  Emerging new biomarkers in obstructive sleep apnea.

Authors:  Shailendra Kapoor
Journal:  Sleep Breath       Date:  2012-11-01       Impact factor: 2.816

Review 4.  Diagnostic capability of biological markers in assessment of obstructive sleep apnea: a systematic review and meta-analysis.

Authors:  Graziela De Luca Canto; Camila Pachêco-Pereira; Secil Aydinoz; Paul W Major; Carlos Flores-Mir; David Gozal
Journal:  J Clin Sleep Med       Date:  2015-01-15       Impact factor: 4.062

5.  The impact of OSA and CPAP treatment on cell adhesion molecules' night-morning variation.

Authors:  Olga Nikitidou; Euphemia Daskalopoulou; Aikaterini Papagianni; Emmanuel Vlachogiannis; Nicholas Dombros; Vassilios Liakopoulos
Journal:  Sleep Breath       Date:  2020-10-26       Impact factor: 2.816

Review 6.  Obstructive Sleep Apnea: From Intermittent Hypoxia to Cardiovascular Complications via Blood Platelets.

Authors:  Agata Gabryelska; Zuzanna M Łukasik; Joanna S Makowska; Piotr Białasiewicz
Journal:  Front Neurol       Date:  2018-08-03       Impact factor: 4.003

Review 7.  Cardiovascular Disorders Triggered by Obstructive Sleep Apnea-A Focus on Endothelium and Blood Components.

Authors:  Jakub Mochol; Jakub Gawrys; Damian Gajecki; Ewa Szahidewicz-Krupska; Helena Martynowicz; Adrian Doroszko
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

8.  Pathophysiologic mechanisms of cardiovascular disease in obstructive sleep apnea syndrome.

Authors:  Carlos Zamarrón; Luis Valdés Cuadrado; Rodolfo Alvarez-Sala
Journal:  Pulm Med       Date:  2013-06-27

Review 9.  Biomarkers to improve diagnosis and monitoring of obstructive sleep apnea syndrome: current status and future perspectives.

Authors:  Konstantinos Archontogeorgis; Evangelia Nena; Nikolaos Papanas; Paschalis Steiropoulos
Journal:  Pulm Med       Date:  2014-11-27

10.  Copeptin: a new predictor for severe obstructive sleep apnea.

Authors:  Halit Çınarka; Servet Kayhan; Mevlüt Karataş; Asiye Yavuz; Aziz Gümüş; Songül Özyurt; Medine Cumhur Cüre; Ünal Şahin
Journal:  Ther Clin Risk Manag       Date:  2015-04-10       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.